By 2050, the cost of manufacturing biomaterial products is expected to drop by 90%, to $0.01/g, while the price per gram is expected drop by about half, to $5/g.
With the cost falling, manufacturers are also able to reduce the amount of raw material they use in the production process.
In addition, manufacturers will also be able to increase the volume of their materials, which will reduce the cost per gram.
This shift in manufacturing processes will lead to a dramatic increase in the availability of biomolecular products, which in turn will boost the value of biomedicine, said Michael A. Gorman, professor of engineering and director of the biomathematics research and development program at MIT.
The manufacturing process of biomonths is relatively simple, requiring only a few materials to be used in the manufacturing process.
It can be done in the laboratory, in the lab for large-scale experiments, or in a large manufacturing plant.
The material for the biomonth is usually made of a synthetic polymer that can be produced in large quantities and has a low cost to make.
The new process, however, allows for a more sophisticated and controlled manufacturing process, making it easier for companies to produce products that can compete with existing pharmaceuticals.
The process has been developed by a group of engineers from MIT and other universities in collaboration with biotechnology companies.
The scientists used nanomaterial nanocomposites, a type of synthetic polymer, to create a biomonter that has properties that make it very flexible, soft and flexible, and can be used as a substrate for other biomonters, such as glass, said Rui Yang, an assistant professor of mechanical engineering at MIT who led the research.
Nanomaterial composites have a high surface area and can have high tensile strength, which makes them suitable for a variety of applications.
The materials used in this new process are composed of polymers, such toluene, polyester, poly(ethylene terephthalate), poly(dimethylsiloxane), polymethyl methacrylate, polymethyl sulfoxide, and poly(methyl methoxyphenylacetone), Yang said.
They are typically made from a polymer such as polyethylene, which has high tensilometric strength, and a small amount of the polymer, which means they are very flexible and can form small, flexible surfaces.
The team also used a new process for producing nanomocomposite sheets that allows them to be deposited into the material.
The sheet has a layer of a material that is not used in a typical biomonitor, and the sheet can be made to have the properties of the material without the need for any further treatment.
The research was supported by the National Science Foundation, the National Institute of Standards and Technology, and MIT.